doi: 10.3389/fnins.2025.1602149 Received 28 March 2025 Accepted 21 May 2025 Published 04 June 2025 Volume 19 - 2025 Edited by Xiao-Yuan Mao, Central South University, China Reviewed by Cai Qi, Yale University, United States Fiorella Colasuonno, University of Rome Tor Vergata, Italy Updates Copyright 2025 Valenzuela-Ahumada, Mercado-Gmez, Viveros-Contreras, Guevara-Guzmn and Camacho-Morales
J Neurol 254(12):16761683 Kumar P, Kalonia H, Kumar A (2010) Nitric oxide mechanism in the protective effect of antidepressants against 3-nitropropionic acid-induced cognitive deficit, glutathione and mitochondrial alterations in animal model of Huntingtons disease
To be compounded under 503A on a routine basis, a substance still needs to fit one of three lawful sources: FDA-approved drug, USP/NF monograph, or 503A bulks list
Your healthcare professional can help you obtain prior authorization by submitting the required paperwork
Considering all these properties, antioxidants are truly the miraculous protectors of our bodies
